Morepen Labs zooms 8% on USFDA nod to market anti-allergy drug

Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22

Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22

Morepen gets USFDA Approval for Fexofinadine (Allegra)

Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

Morepen Laboratories receives USFDA approval for Fexofinadin

Morepen gets USFDA nod to market generic anti-allergy drug

Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride

Morepen gets USFDA nod for anti-allergy drug

Morepen Labs anti-allergy drug Fexofinadine gets USFDA approval

Morepen gets USFDA Approval for Fexofinadine

Noticias farmacéuticas: Últimas noticias farmacéuticas, noticias y actualizaciones farmacéuticas indias

Actualités pharmaceutiques : dernières actualités pharmaceutiques, actualités pharmaceutiques indiennes et mises à jour

Morepen Labs’ exports to get ‘major boost’ with FDA nod for Allegra

Morepen Laboratories shines on getting USFDA’s nod for anti-allergy drug Fexofinadine Hydrochloride

Morepen gets USFDA nod for Fexofinadine (Allegra)

Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)

Morepen Laboratories : gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22

Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4'FY22

Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)

This news turns out to be a lucky charm for Morepen Laboratories; read to find out more!

Morepen gets USFDA nod to market generic anti-allergy drug

Morepen bags US FDA approval for allergy drug Allegra

Morepen gets USFDA nod to market generic anti-allergy drug

Morepen gets USFDA nod to market generic anti-allergy drug Fexofinadine Hydrochloride

Morepen Laboratories receives USFDA approval

Morepen Labs has seen 36% growth in medical devices in Q2, Dr Morepen could be an IPO candidate: Sushil Suri

Morepen Laboratories gets USFDA nod for Fexofinadine

Morepen Laboratories receives USFDA approval for anti-allergy drug Fexofinadine Hydrochloride

Morepen Laboratories receives USFDA approval for Fexofinadine Hydrochloride (Allegra)

Morepen Laboratories gets USFDA nod to market generic anti-allergy drug

Morepen gets USFDA nod to market generic anti-allergy drug

Morepen gets USFDA Approval for Fexofinadine (Allegra)Expected to start export in Q4’FY22

Morepen gets USFDA Approval for Fexofinadine (Allegra) Expected to start export in Q4’FY22